Caption Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-75,000
| Closed | -$7.62M | – | 1687 |
|
|
2025
Q4 | $7.62M | Hold |
75,000
| – | – | 0.05% | 400 |
|
|
2025
Q3 | $4.1M | Buy |
75,000
+17,000
| +29% | +$849K | 0.03% | 568 |
|
|
2025
Q2 | $3.08M | Buy |
+58,000
| New | +$2.95M | 0.03% | 575 |
|
|
2025
Q1 | – | Sell |
-226,800
| Closed | -$12.7M | – | 1676 |
|
|
2024
Q4 | $12.7M | Buy |
+226,800
| New | +$14.1M | 0.12% | 147 |
|
|
2024
Q2 | – | Sell |
-172,500
| Closed | -$11.9M | – | 1266 |
|
|
2024
Q1 | $11.9M | Sell |
172,500
-302,000
| -64% | -$19.1M | 0.18% | 129 |
|
|
2023
Q4 | $35.1M | Buy |
474,500
+118,300
| +33% | +$7.75M | 0.47% | 34 |
|
|
2023
Q3 | $24.3M | Sell |
356,200
-334,200
| -48% | -$28.4M | 0.37% | 51 |
|
|
2023
Q2 | $64.8M | Buy |
690,400
+307,600
| +80% | +$24M | 1.15% | 8 |
|
|
2023
Q1 | $26M | Sell |
382,800
-32,800
| -8% | -$2.11M | 0.5% | 45 |
|
|
2022
Q4 | $20.6M | Buy |
415,600
+63,600
| +18% | +$2.6M | 0.32% | 65 |
|
|
2022
Q3 | $11.4M | Buy |
352,000
+302,000
| +604% | +$12.5M | 0.16% | 142 |
|
|
2022
Q2 | $1.97M | Sell |
50,000
-10,600
| -17% | -$567K | 0.03% | 672 |
|
|
2022
Q1 | $4.24M | Buy |
60,600
+20,000
| +49% | +$1.46M | 0.05% | 488 |
|
|
2021
Q4 | $3.16M | Buy |
+40,600
| New | +$3.58M | 0.04% | 622 |
|
|
2021
Q1 | – | Sell |
-63,600
| Closed | -$8.42M | – | 1151 |
|
|
2020
Q4 | $8.42M | Buy |
63,600
+48,600
| +324% | +$5.88M | 0.19% | 148 |
|
|
2020
Q3 | $1.53M | Buy |
+15,000
| New | +$1.3M | 0.04% | 514 |
|
|
2020
Q1 | – | Sell |
-345,300
| Closed | -$31.9M | – | 914 |
|
|
2019
Q4 | $31.9M | Buy |
345,300
+186,500
| +117% | +$16.4M | 1.07% | 9 |
|
|
2019
Q3 | $14.3M | Buy |
158,800
+25,000
| +19% | +$2.85M | 0.75% | 26 |
|
|
2019
Q2 | $15.8M | Sell |
133,800
-25,000
| -16% | -$2.52M | 0.8% | 20 |
|
|
2019
Q1 | $13.8M | Sell |
158,800
-198,800
| -56% | -$16.9M | 0.76% | 19 |
|
|
2018
Q4 | $22.6M | Buy |
+357,600
| New | +$24.5M | 1.8% | 4 |
|
|
2018
Q1 | – | Sell |
-200,000
| Closed | -$10.5M | – | 248 |
|
|
2017
Q4 | $10.5M | Buy |
+200,000
| New | +$10.7M | 1.09% | 25 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Caption Management's EXAS Position: Q1 2026 in Review
Caption Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 170,679 shares — an estimated $17.3M sold.
Caption Management first reported a position in EXAS in Q4 2018 and held it in 14 quarters. The position peaked at $17.3M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Caption Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Caption Management sold 170,679 Exact Sciences shares in Q1 2026, an estimated $17.3M.
- Caption Management first reported a position in Exact Sciences in Q4 2018 and held it in 14 quarters.
- Caption Management's Exact Sciences position peaked at $17.3M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.